Page last updated: 2024-10-15

frondoside a

Description

frondoside A: from the North Atlantic commercially harvested sea cucumber Cucumaria frondosa [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID146026187
MeSH IDM0529095

Synonyms (3)

Synonym
frondoside a
HY-135896
CS-0116117

Research Excerpts

Overview

Frondoside A is a triterpenoid glycoside isolated from the Atlantic sea cucumber, Cucumaria frondosa. It has potent antitumor effects in various cancers.

ExcerptReference
"Frondoside A is a natural glycoside extracted from the sea cucumber, Cucumaria frondosa, which has been used as a traditional remedy, recently, the extract was found to have potential anti-tumor properties."( Frondoside A is a potential anticancer agent from sea cucumbers.
Sajwani, FH,
)
"Frondoside A is a triterpenoid glycoside originally isolated from the sea cucumber, Cucumaria frondosa that has potent antitumor effects in various cancers."( Frondoside A potentiates the effects of conventional therapeutic agents in acute leukemia.
Adrian, TE; Collin, P; Sajwani, FH, 2017
)
"Frondoside A is a triterpenoid glycoside from the Atlantic Sea Cucumber, "( The Anti-Cancer Effects of Frondoside A.
Adrian, TE; Collin, P, 2018
)
"Frondoside A is a triterpenoid glycoside isolated from the Atlantic sea cucumber, Cucumaria frondosa."( Frondoside A enhances the antiproliferative effects of gemcitabine in pancreatic cancer.
Adem, A; Adrian, TE; Al Shemaili, J; Attoub, S; Collin, P; Hellman, B; Mensah-Brown, E; Nyberg, F; Parekh, K; Thomas, SA, 2014
)
"Frondoside A is a pentaoside having an acetyl moiety at the aglycon ring and xylose as a third monosaccharide residue. "( Differential effects of triterpene glycosides, frondoside A and cucumarioside A2-2 isolated from sea cucumbers on caspase activation and apoptosis of human leukemia cells.
Avilov, SA; Fedorov, SN; Jin, JO; Kwak, JY; Park, JI; Rasskazov, VA; Shastina, VV; Shin, SW; Stonik, VA; Xu, Q, 2009
)
"Frondoside A is a triterpenoid glycoside isolated from the sea cucumber, Cucumaria frondosa."( Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts.
Adrian, TE; Ahmed Al Sultan, M; Al Marzouqi, N; Arafat, K; Attoub, S; Collin, P; Iratni, R; Mester, J; Nemmar, A; Yasin, J, 2011
)
"Frondoside A is a triterpenoid glycoside isolated from the sea cucumber, Cucumaria frondosa and was shown to be a highly safe compound."( Frondoside a suppressive effects on lung cancer survival, tumor growth, angiogenesis, invasion, and metastasis.
Adrian, TE; Al Sultan, MA; Arafat, K; Attoub, S; Bracke, M; Collin, P; De Wever, O; GĂ©laude, A; Takahashi, T, 2013
)

Effects

ExcerptReference
"Frondoside A has a weak effect upon immunoglobulin (Ig) M production after immunization with sheep erythrocytes in mice."( Immunomodulatory properties of frondoside A, a major triterpene glycoside from the North Atlantic commercially harvested sea cucumber Cucumaria frondosa.
Agafonova, IG; Aminin, DL; Avilov, SA; Collin, PD; Kalinin, VI; Silchenko, AS; Stonik, VA; Woodward, C, 2008
)

Actions

ExcerptReference
"Frondoside A stimulates an increase in the number of antibody plaque-forming cells (normally B-cells in spleen) in vivo with a maximal stimulatory effect at a concentration of 0.2 microg per mouse (stimulatory index, 1.86)."( Immunomodulatory properties of frondoside A, a major triterpene glycoside from the North Atlantic commercially harvested sea cucumber Cucumaria frondosa.
Agafonova, IG; Aminin, DL; Avilov, SA; Collin, PD; Kalinin, VI; Silchenko, AS; Stonik, VA; Woodward, C, 2008
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (9.52)29.6817
2010's14 (66.67)24.3611
2020's5 (23.81)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]